{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.1444.3.144","meta":{"versionId":"6","lastUpdated":"2021-03-06T01:00:18.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"American Society of Clinical Oncology Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-07-06"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-03-06"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.144","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.1444.3.144"}],"version":"20210306","name":"NetupitantPalonosetronOral","title":"Netupitant Palonosetron Oral","status":"active","experimental":false,"date":"2021-03-06T01:00:18-05:00","publisher":"American Society of Clinical Oncology Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts of medication Netupitant Palonosetron.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Netupitant Palonosetron; generic; prescribable; oral.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1552343","display":"netupitant 300 MG / palonosetron 0.5 MG Oral Capsule"}]}]},"expansion":{"identifier":"urn:uuid:0e57c2ae-9bb8-4c3c-885b-22a18a05910c","timestamp":"2023-12-11T01:18:26-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1552343","display":"netupitant 300 MG / palonosetron 0.5 MG Oral Capsule"}]}}